Provozní marže společnosti Kazia Therapeutics

Jaká je hodnota metriky Provozní marže společnosti Kazia Therapeutics?

Hodnota metriky Provozní marže společnosti Kazia Therapeutics Limited je -248,657.00%

Jaká je definice metriky Provozní marže?



Provozní marže (Operation margin) je procentuální poměr provozních příjmů z čistých tržeb.

Operating margin is an indicator of profitability and is often used to compare the profitability of companies and industries of differing sizes. Companies are collections of projects and markets, individual areas can be judged on how successful they are at adding to the corporate net profit. Not all projects are of equal size, however, and one way to adjust for size is to divide the profit by sales revenue. The resulting ratio is the percentage of sales revenue that gets 'returned' to the company as net profits after all the related costs of the activity are deducted.

Provozní marže společností v sektoru Health Care sektor na ASX ve srovnání se společností Kazia Therapeutics

Čemu se věnuje společnost Kazia Therapeutics?

Kazia Therapeutics Limited, an oncology-focused biotechnology company, develops anti-cancer drugs. Its lead development candidate is GDC-0084, a small molecule, brain-penetrant inhibitor of the PI3K/Akt/mTor pathway, which is developed as a potential therapy for glioblastoma. The company is also developing Cantrixil, which is being developed for the treatment of ovarian cancer and is in hospitals across Australia and the United States under an Investigational New Drug application. Kazia Therapeutics Limited has collaboration agreements St Jude Childrens Hospital; Dana-Farber Cancer Institute; Alliance for Clinical Trials in Oncology; Memorial Sloan Kettering Cancer Centre; and University of Newcastle. The company was formerly known as Novogen Limited and changed its name to Kazia Therapeutics Limited in November 2017. Kazia Therapeutics Limited was founded in 1994 and is based in Sydney, Australia.

Firmy s metrikou provozní marže podobnou společnosti Kazia Therapeutics



  • Hodnota metriky Provozní marže společnosti Concert Pharmaceuticals Inc je -295,878.57%
  • Hodnota metriky Provozní marže společnosti Petro Matad je -277,500.00%
  • Hodnota metriky Provozní marže společnosti Mydecine Innovations je -267,852.47%
  • Hodnota metriky Provozní marže společnosti Oragenics Inc je -263,285.20%
  • Hodnota metriky Provozní marže společnosti Mont Royal Resources je -260,037.90%
  • Hodnota metriky Provozní marže společnosti Evrim Resources je -254,529.87%
  • Hodnota metriky Provozní marže společnosti Kazia Therapeutics je -248,657.00%
  • Hodnota metriky Provozní marže společnosti 3D Oil je -244,712.43%
  • Hodnota metriky Provozní marže společnosti DeepMarkit je -239,653.20%
  • Hodnota metriky Provozní marže společnosti Errawarra Resources Ltd je -230,022.95%
  • Hodnota metriky Provozní marže společnosti Mayur Resources Ltd je -227,762.38%
  • Hodnota metriky Provozní marže společnosti Hannans je -217,381.50%
  • Hodnota metriky Provozní marže společnosti Tocagen je -194,211.11%